Results: In RCC specimens, (q)RT-PCR and IHC assessment of expression of candidate immune genes previously found to be up-regulated in PD-L1+ vs. PD-L1(−) melanomas showed that none of these molecules was differentially expressed according to clinical outcome. The gene discussed is CD274; the disease is melanoma.